-+ 0.00%
-+ 0.00%
-+ 0.00%

EUROPEAN COMMISSION GRANTS MARKETING AUTHORISATION FOR NEZGLYAL® (LERIGLITAZONE), THE FIRST PHARMACOLOGICAL TREATMENT APPROVED FOR CEREBRAL ADRENOLEUKODYSTROPHY (CALD), A RARE NEURODEGENERATIVE DISEASE

路透·09/25/2026 07:00:14

請登錄查看新聞詳情